Skip to main content
  • Insights Open link menu
    Insights
    • Stories
    • Events
    • Resources
    • News
  • Sustainability Open link menu
    Sustainability
    • Our Approach to Sustainability
    • Climate and Environment
    • Sustainable Supply Chain
    • Our People
    • Supporting the Community
    • Reports Archive
    • Supplemental ESG information
  • Investors Open link menu
    Investors
    • News and Events Open link menu
      News and Events
      • Board Meeting
      • Disclosures to Stock Exchange
      • General Meeting
      • Postal Ballot
      • Corporate Action
      • Credit Rating
    • Financials and Reports Open link menu
      Financials and Reports
      • Quarterly Results
      • Annual Report
      • Subsidiary Financials
      • Annual Return
    • Investor Meetings Open link menu
      Investor Meetings
      • Analyst Meets
      • Investor Presentations
      • Transcripts
      • Investor Call Recordings
    • Corporate Governance Open link menu
      Corporate Governance
      • Committees of the Board
      • Policies and Documents
      • Corporate Governance Reports
    • Disclosures under Regulation 46 of SEBI Listing Regulations
    • Investor Services Open link menu
      Investor Services
      • Shareholding
      • Unpaid and Unclaimed Dividend
      • Share Price
      • Equity and Dividend History
      • IEPF Details
      • Investor Contacts / Grievances
      • TDS Related Information on Dividend
      • Investor Forms and Services
      • Online Dispute Resolution Portal
  • Careers Open link menu
    Careers
    • People
    • Learning at Neuland
    • Careers at Neuland
  • Contact us
Header logo
  • About Us Open link menu
    About Us

    Since inception, at Neuland our purpose has been to build a quality-conscious pharmaceutical company high on integrity. We work with over 500 pharma and biotech organizations, advancing healthcare solutions, to help create a healthier world.

    About Us
    • Our Business
    • Our Brand
    • Our Vision and Values
    • Our History
    • Our Business Model
    • Leadership
    • Our Facilities Open link menu
      Our Facilities
      • R & D Centre
      • Unit I - Bonthapally
      • Unit II - Pashamylaram
      • Unit III - Gaddapotharam
    About us

    close Menu

  • Our Capabilities Open link menu
    Our Capabilities

    Our robust enabling capabilities ensure the seamless execution of our core services and form the backbone of our operations. This guarantees that we consistently deliver high-quality, compliant and innovative solutions to our clients.

    Our Capabilities
    • Chemistry and Reactions
    • Supply Chain Management
    • Quality Control & Assurance
    • Project Management
    • Regulatory CMC Support
    • Intellectual Property
    Our Capabilities

    close Menu

  • Generic APIs Open link menu
    Generic APIs

    With over 4 decades of expertise and a strong focus on innovation, we provide a diverse portfolio of APIs across various therapeutic categories. Our strategic priority is to cater to quality-conscious customers and offer products differentiated by technology.

    Generic APIs
    • API Products
    • Download Brochure
    Product List
    Product List Brochure
    Link

    close Menu

  • CDMO Services Open link menu
    CDMO Services

    At Neuland we prioritize our customer needs, working collaboratively to ensure project success. We provide an end-to-end continuum of customised NCE development services from lab to commercial supply.

    CDMO Services
    • Custom Development Open link menu
      Custom Development
      • Chemistry and Process Development
      • Analytical Development & Validation
      • Process Safety & Engineering Assessment
      • Phase Appropriate Development
    • Custom Manufacturing
    • Peptides Open link menu
      Peptides
      • Process Development
      • Large scale cGMP Manufacturing
      • Analytical R&D
      Peptides
      • Process Development
      • Large scale cGMP Manufacturing
      • Analytical R&D
    CDMO Brochure
    CDMO Brochure
    Link

    close Menu

  • Insights Open link menu
    Insights
    • Stories
    • Events
    • Resources
    • News
  • Sustainability Open link menu
    Sustainability
    • Our Approach to Sustainability
    • Climate and Environment
    • Sustainable Supply Chain
    • Our People
    • Supporting the Community
    • Reports Archive
  • Investors Open link menu
    Investors
    • News and Events Open link menu
      News and Events
      • Board Meeting
      • Disclosures to Stock Exchange
      • General Meeting
      • Postal Ballot
      • Corporate Action
      • Credit Rating
    • Financials and Reports Open link menu
      Financials and Reports
      • Quarterly Results
      • Annual Report
      • Subsidiary Financials
      • Annual Return
    • Investor Meetings Open link menu
      Investor Meetings
      • Analyst Meets
      • Investor Presentations
      • Transcripts
      • Investor Call Recordings
    • Corporate Governance Open link menu
      Corporate Governance
      • Committees of the Board
      • Policies and Documents
      • Corporate Governance Reports
    • Disclosures under Regulation 46 of SEBI Listing Regulations
    • Investor Services Open link menu
      Investor Services
      • Shareholding
      • Unpaid and Unclaimed Dividend
      • Share Price
      • Equity and Dividend history
      • IEPF Details
      • Investor Contacts / Grievances
      • TDS Related Information on Dividend
      • Investor Forms and Services
      • Online Dispute Resolution Portal
  • Careers Open link menu
    Careers
    • People
    • Learning at Neuland
    • Careers at Neuland
  • Contact us
  • Please fill out this field

Please ENTER to search

Please fill out this field
Stories
Breadcrumbs
  • Home
  • Insights
  • Stories

Stories

Breadcrumbs
  • Home
  • Insights
  • Stories
solid phase peptide synthesis
May 16, 2025
What Is Solid Phase Peptide Synthesis? Process, Uses & Benefits
Read more
BCMS
May 07, 2025
Business Continuity Management—the Next Frontier in API Supply Chain Security
Read more
cdmo-for-biotech
May 06, 2025
How CDMOs Help Biotech Advance and Navigate Drug Development and Manufacturing Complexities
Read more
choosing-the-right-cdmo-partner
May 02, 2025
The Ultimate Guide to Selecting a CDMO Partner
Read more
what-is-cgmp-in-the-pharmaceutical-industry
Apr 29, 2025
Understanding cGMP Compliance for Pharmaceutical Manufacturing Excellence
Read more
Why contract manufacturing for pharmaceutical matters
Apr 14, 2025
Why Pharma Giants Are Outsourcing Drug Manufacturing to CDMOs
Read more
Outsourcing Drug Manufacturing & Development to CDMO
Apr 11, 2025
All You Need to Know About Outsourcing Drug Manufacturing & Development to CDMO
Read more
5 Reasons
Apr 01, 2025
5 Reasons Why More Pharma Companies Are Strengthening CDMO Relationships
Read more
Core Elements of Quality and Risk Management Strategies
Mar 11, 2025
Quality Risk Management in Pharmaceutical Industry
Read more
Neuland Announces New Vision and Values Statements
Jan 07, 2025
Neuland Announces New Vision and Values Statements
Read more
Essential Role of Intellectual Property
Nov 14, 2024
The Essential Role of Intellectual Property Expertise in a Pharmaceutical API Company
Read more
Three-Pillar Project Management Strategy
Oct 03, 2024
Achieving Drug Development Success: Inside Neuland’s Three-Pillar Project Management Strategy
Read more
peptide trends
Sep 02, 2024
From the Neuland Reading Room: Peptide Trends in 2024
Read more
Zero Liquid Discharge
Aug 02, 2024
Zero Liquid Discharge: A Pharma Industry Commitment to Environmental Sustainability
Read more
The Pharma Supply Chain: Reshaping Itself for The New Normal
Jul 03, 2024
The Pharma Supply Chain: Reshaping Itself for The New Normal
Read more
Redefining Excellence: Neuland Unveils a Refreshed Brand Identity
Jun 07, 2024
Redefining Excellence: Neuland Unveils a Refreshed Brand Identity
Read more
From the Neuland Reading Room: A Check-in on 2024 Trends in the CDMO Industry
May 02, 2024
From the Neuland Reading Room: A Check-in on 2024 Trends in the CDMO Industry
Read more
How to Ensure Effective Technology Transfer to CDMOs
Mar 28, 2024
How to Ensure Effective Technology Transfer to CDMOs
Read more
Why Agility Matters When Choosing an API Contract Manufacturing Partner
Mar 04, 2024
Why Agility Matters When Choosing an API Contract Manufacturing Partner
Read more
APIParticleSizePart2
Feb 01, 2024
API Particle Size Part 2: New & Emerging Technologies Impacting Particle Size
Read more
API Particle Size Part I: Overcoming the Challenges to Ensure Quality Pharmaceutical Products
Dec 21, 2023
API Particle Size Part I: Overcoming the Challenges to Ensure Quality Pharmaceutical Products
Read more
Pharmaceutical
Dec 04, 2023
Scaling-up Active Pharmaceutical Ingredient (API) Chemistry for Phase 3 Clinical Trials and Bulk Manufacturing for a Potentially Novel Treatment for Schizophrenia
Read more
R&D Expert Talks Pharma API Scale Optimization
Sep 01, 2023
R&D Expert Talks Pharma API Scale Optimization
Read more
The Crucial Role of Crystallization in Drug Substances Development
Aug 01, 2023
The Crucial Role of Crystallization in Drug Substances Development
Read more
What Pharmacological Advantages Can Deuterated APIs Deliver?
Jul 06, 2023
What Pharmacological Advantages Can Deuterated APIs Deliver?
Read more
pharma-manufacturing
Jun 01, 2023
Integrating Sustainability into Pharma Manufacturing
Read more
8 Ways Effective Supply Chain Management Can Minimize Pharmaceutical Supply Chain Challenges
Apr 27, 2023
8 Ways Effective Supply Chain Management Can Minimize Pharmaceutical Supply Chain Challenges
Read more
drug-pandemic
Apr 18, 2023
Advancing a Cholesterol Lowering Drug at the Height of the Pandemic
Read more
Sustainable Businesses
Apr 01, 2023
ESG in Pharma: Building Sustainable Businesses
Read more
poster image
Feb 06, 2023
How Neuland’s Process Engineering Lab Supports Robust Design and Minimizes Risk
Read more
customer-centricity
Jan 01, 2023
Putting Customers First: Customer Centricity in Pharma API Manufacturing
Read more
3 Key Elements of a Successful Hydrogenation Scale-Up
Aug 30, 2022
3 Key Elements of a Successful Hydrogenation Scale-Up
Read more
analyze-suppliers
May 27, 2022
Why is Pharmaceutical Green Chemistry Use on the Rise?
Read more
RegulatoryStartingMaterials
Apr 04, 2022
Regulatory Starting Materials: How to Source, Analyze and Validate Suppliers (Part I)
Read more
Exploring Neuland
Jan 14, 2022
Exploring Neuland’s Therapeutic Segments: Focus on CNS
Read more
GreenChemistrybyDesign
Jan 03, 2022
Green Chemistry by Design (GCbD): The Earlier, The Better for Pharmaceutical APIs
Read more
DeuteratedDrugMolecules
Dec 01, 2021
Deuterated Drug Molecules: Perfecting the Gamechanger
Read more
What Does it Take to Become a Specialist in Late-Phase CMS?
Sep 03, 2021
What Does it Take to Become a Specialist in Late-Phase CMS?
Read more
API Production: Building a Process Safety Culture
May 02, 2021
API Production: Building a Process Safety Culture
Read more
LookingAPIupplier5ThingsConsider
Sep 13, 2020
Looking for an API Supplier? 5 Things to Consider (Updated)
Read more
Nitrosamine Impurities
Mar 02, 2020
Nitrosamine Impurities and How Companies are Addressing the Crisis
Read more
Successful Pharmaceutical Project Management
Aug 17, 2019
Successful Pharmaceutical Project Management
Read more
Complex Synthesis in Action: Achieving a Commercial-Scale 16 AA Peptide
Jun 16, 2019
Complex Synthesis in Action: Achieving a Commercial-Scale 16 AA Peptide
Read more
A Guide to Sourcing Pharmaceutical Peptide APIs
May 19, 2019
A Guide to Sourcing Pharmaceutical Peptide APIs
Read more
CaseStudiesNeulandProcessEngineeringLab
Aug 31, 2018
Case Studies from Neuland’s Process Engineering Lab
Read more
Overcoming Challenges in Complex Peptide Purification
Jun 01, 2018
Overcoming Challenges in Complex Peptide Purification
Read more
Welcome, Unit 3!
Apr 22, 2018
Welcome, Unit 3!
Read more
QbD and Evaluating
Apr 02, 2018
QbD and Evaluating ‘What-If’ Drug Manufacturing Scenarios
Read more
NCEs Versus Generics – Adjusting Project Tactics & Objectives to Maximize Success
Feb 10, 2018
NCEs Versus Generics – Adjusting Project Tactics & Objectives to Maximize Success
Read more
Synthetic Route Scouting: Factors to Improve API Manufacturing
Jan 07, 2018
Synthetic Route Scouting: Factors to Improve API Manufacturing
Read more
How to Select a Peptide Synthesis Technique
Oct 01, 2017
How to Select a Peptide Synthesis Technique
Read more
Leveraging QbD for API Scale Up
Sep 17, 2017
Leveraging QbD for API Scale Up
Read more
5 Common Challenges Scaling Up an API
Sep 03, 2017
5 Common Challenges Scaling Up an API
Read more
HowProcessEngineeringTechniquesResult
Feb 05, 2017
How Process Engineering Techniques Result in Cost-Effective Products
Read more
API Manufacture of Deuterated Molecules
Dec 04, 2016
API Manufacture of Deuterated Molecules
Read more
Advantages of a Pure-Play API Contract Manufacturer
Nov 06, 2016
Advantages of a Pure-Play API Contract Manufacturer
Read more
APIsContinuousFlowManufacturing
Aug 21, 2016
APIs & Continuous Flow Manufacturing
Read more
ChallengesAPIMicronizationTechniques
Jun 05, 2016
Challenges with API Micronization Techniques for Use in Injectables and Medical Devices
Read more
Advances in the Synthesis of Peptide Therapeutics: Clear Advantages…and Some Barriers
Feb 07, 2016
Advances in the Synthesis of Peptide Therapeutics: Clear Advantages…and Some Barriers
Read more
GenotoxicImpuritiesIncreasingVigilance
Dec 06, 2015
Genotoxic Impurities – Increasing Vigilance, But Still Some Uncertainty
Read more
6 Properties of API Synthesis that Affect Yield, Delivery Date & Purity
Jun 01, 2015
6 Properties of API Synthesis that Affect Yield, Delivery Date & Purity
Read more
Contract Drug Manufacturing R&D: from Route Scouting to Kilo Labs
Jan 19, 2015
Contract Drug Manufacturing R&D: from Route Scouting to Kilo Labs
Read more
BenefitsofSynthesisScouting
Jan 04, 2015
The Benefits of Synthesis Scouting
Read more
AnalyticalCapabilitiesandDrugQuality
Sep 23, 2014
Analytical Capabilities and Drug Quality – Key to Successful Pharma Outsourcing
Read more
The New Look of Neuland
Jul 01, 2014
The New Look of Neuland
Read more
Peptide Synthesis: Solution Phase, Solid Phase or Hybrid?
Nov 03, 2013
Peptide Synthesis: Solution Phase, Solid Phase or Hybrid?
Read more
Neuland Labs Receives 2013 CMO Leadership Award for Regulatory Excellence
Oct 18, 2013
Neuland Labs Receives 2013 CMO Leadership Award for Regulatory Excellence
Read more

Load More

  • MailContact Us
Neuland Labs
Quick links
  • About us
  • Our Capabilities
  • Generic APIs
  • CDMO Services
  • Peptide Development
  • Stories
  • Sustainability
  • Investors
  • Careers
Get in touch

Contact us

Connect with us
  • Terms and Conditions
  • Privacy policy
  • Cookie policy
  • Cookie settings
  • Site Map

© 2024 Neuland Laboratories Ltd. All rights reserved.